DiscGenics announced allowance of 9 additional patents, including two in the U.S. and seven in EU markets. The company is developing spinal stem cell therapeutics to treat disc disease.
Medovex conducted a successful live tissue test of the DenerveX™ system under the most stringent standards required by FDA and other regulatory agencies. The device is intended to treat pain associated with facet joint syndrome.
CMS issued its 2017 Final Hospital Outpatient Prospective Payment System and Ambulatory Surgical Center payment rule for MIS sacroiliac joint fusion. New payments are effective January 2017.
Intellijoint Surgical secured US $11.0MM in Series A Financing. Funds will support expanded U.S. launch of the intellijoint HIP® mini-optical navigation tool.
Onkos Surgical received FDA 510(k) clearance to market the ELEOS™ Limb Salvage System to treat bone loss due to cancer, trauma or previous surgical procedures. Full launch is slated for 1Q17.
DePuy Synthes announced the availability of Expert Tibial Nail PROtect, featuring a resorbable antibiotic coating designed to provide protection from bacterial colonization in patients at high risk of infection.Â
DePuy Synthes Spine launched the ZERO-P NATURAL™ Plate, designed for use with the CC Natural allograft spacer, for spinal fusion procedures in the neck.